Consider Selegiline for managing Parkinson’s disease symptoms or depression. This medication offers a unique mechanism of action, acting primarily as a selective monoamine oxidase type B (MAO-B) inhibitor. This means it specifically targets the breakdown of dopamine, a neurotransmitter crucial for motor control and mood regulation.
Studies show Selegiline can improve motor function in Parkinson’s patients, reducing tremors, rigidity, and bradykinesia. For those battling depression, Selegiline may offer an alternative to other antidepressants, particularly when combined with L-dopa in Parkinson’s cases. However, remember that individual responses vary, and consulting your physician is paramount before starting any medication.
Specific dosages depend on the condition being treated and individual patient factors. Your doctor will carefully determine the appropriate starting dose and monitor your progress to adjust as needed. Common side effects include insomnia, nausea, and orthostatic hypotension. Promptly report any adverse reactions to your healthcare provider. They can then assess the situation and adjust treatment accordingly to manage potential issues.
Always follow your doctor’s instructions precisely. Never alter your dosage without consulting a medical professional. Understanding the potential benefits and risks is key to making informed decisions about your healthcare. This information serves as an overview, and detailed discussion with a healthcare professional is recommended before starting Selegiline treatment.
